Clinical Trial

Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement

Completed Phase 2/3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether administration of a pectoral nerve blocks (Pecs I and II) with 0.25% bupivacaine are more effective as compared to placebo to provide analgesia for cardiac implantable electronic device (CIED) placement in cardiac electrophysiology lab
Protocol Amendment History 3 changes
critical Trial completed 2026-07-31
notable Primary completion moved earlier: 2025-03 -> 2024-03-29 2026-07-31
minor Completion moved earlier: 2025-03 -> 2024-03-29 2026-07-31
Trial Details
NCT Number NCT05283980
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Pain, Postoperative, Pain, Acute, Pain, Chest, Pain, Satisfaction, Patient, Opioid Use, Unspecified, Opioids; Harmful Use
Enrollment 62 participants
Start Date 2022-11-17
Primary Completion 2024-03-29 (estimated)
Study Completion 2024-03-29 (estimated)
Updated on ClinicalTrials.gov 2026-07-30